Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-25-235805·PALISADE BIO, INC.
Schedule 13G ownership disclosure
Palisade Bio, Inc.
Common Stock, $0.01 par value · CUSIP: 696389402
Event date: 2025-10-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 12,243,018 · Class: 9.99%
- Joseph Edelman
Shares: 12,243,018 · Class: 9.99%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 12,243,018 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-235805
- Form type
- SCHEDULE 13G
- Filer
- PALISADE BIO, INC.
- CIK
- CIK 1357459
- Filed
- Oct 09, 2025
- Reporting period
- Oct 02, 2025
- Description
- Schedule 13G beneficial ownership